These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Increased serum levels of fractalkine and mobilisation of CD34 Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472 [TBL] [Abstract][Full Text] [Related]
6. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Tourkina E; Bonner M; Oates J; Hofbauer A; Richard M; Znoyko S; Visconti RP; Zhang J; Hatfield CM; Silver RM; Hoffman S Fibrogenesis Tissue Repair; 2011 Jul; 4(1):15. PubMed ID: 21722364 [TBL] [Abstract][Full Text] [Related]
7. Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay. Cutolo M; Soldano S; Montagna P; Trombetta AC; Contini P; Ruaro B; Sulli A; Scabini S; Stratta E; Paolino S; Pizzorni C; Smith V; Brizzolara R Arthritis Res Ther; 2018 Jul; 20(1):157. PubMed ID: 30053831 [TBL] [Abstract][Full Text] [Related]
8. Derivation of multipotent progenitors from human circulating CD14+ monocytes. Seta N; Kuwana M Exp Hematol; 2010 Jul; 38(7):557-63. PubMed ID: 20362030 [TBL] [Abstract][Full Text] [Related]
9. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235 [TBL] [Abstract][Full Text] [Related]
10. Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis. Yamaguchi Y; Kuwana M Histol Histopathol; 2013 Feb; 28(2):175-83. PubMed ID: 23275301 [TBL] [Abstract][Full Text] [Related]
11. A novel population of mesenchymal progenitors with hematopoietic potential originated from CD14 peripheral blood mononuclear cells. Hu G; Liu P; Feng J; Jin Y Int J Med Sci; 2010 Dec; 8(1):16-29. PubMed ID: 21209798 [TBL] [Abstract][Full Text] [Related]
12. Elevated Fibronectin Levels in Profibrotic CD14 Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G Front Immunol; 2021; 12():642891. PubMed ID: 34504485 [TBL] [Abstract][Full Text] [Related]
13. Endothelial differentiation potential of human monocyte-derived multipotential cells. Kuwana M; Okazaki Y; Kodama H; Satoh T; Kawakami Y; Ikeda Y Stem Cells; 2006 Dec; 24(12):2733-43. PubMed ID: 16888284 [TBL] [Abstract][Full Text] [Related]
14. CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis. Campioni D; Lo Monaco A; Lanza F; Moretti S; Ferrari L; Fotinidi M; La Corte R; Cuneo A; Trotta F Haematologica; 2008 Aug; 93(8):1233-7. PubMed ID: 18556411 [TBL] [Abstract][Full Text] [Related]
15. Kinetics of circulating progenitor cell mobilization during submaximal exercise. Niemiro GM; Parel J; Beals J; van Vliet S; Paluska SA; Moore DR; Burd NA; De Lisio M J Appl Physiol (1985); 2017 Mar; 122(3):675-682. PubMed ID: 28082336 [TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells mobilization after maximal exercise according to heart failure severity. Kourek C; Karatzanos E; Psarra K; Georgiopoulos G; Delis D; Linardatou V; Gavrielatos G; Papadopoulos C; Nanas S; Dimopoulos S World J Cardiol; 2020 Nov; 12(11):526-539. PubMed ID: 33312438 [TBL] [Abstract][Full Text] [Related]
17. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients. Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812 [TBL] [Abstract][Full Text] [Related]
18. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028 [TBL] [Abstract][Full Text] [Related]
19. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow endothelial progenitors are defective in systemic sclerosis. Del Papa N; Quirici N; Soligo D; Scavullo C; Cortiana M; Borsotti C; Maglione W; Comina DP; Vitali C; Fraticelli P; Gabrielli A; Cortelezzi A; Lambertenghi-Deliliers G Arthritis Rheum; 2006 Aug; 54(8):2605-15. PubMed ID: 16868984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]